Casandra
Casandra Test Code QD40158Version 1 (DRAFT)
Performing Lab
Post COVID-19 Coagulation Panel
Also known as: SARS-COV-2, Post-COVD-19, Post COVID Conditions, Post COVID Lethargy, CDC
Clinical Use
Order TestUse
About 10–30% of patients continue with lingering symptoms four or more weeks after COVID‑19 infection, including those who had mild or no symptoms—termed post‑COVID conditions. The Centers for Disease Control (CDC) provide interim guidance for assessment and testing of patients with post‑COVID conditions. This panel is intended for use in evaluating persistent symptoms, 12 weeks or more post‑COVID, to assess coagulation status.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Other
Biomarkers
2 components
D-Dimer, QuantitativeFibrinogen Activity, Clauss
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Not provided.
Similar Tests
Other tests from different labs that may be relevant
COVID-19 Induced Thrombotic Microangiopathy Profile
Labcorp
Disseminated Intravascular Coagulation (DIC) Profile, Comprehensive Plus
Labcorp
COVID-19 Severe Disease Progression Risk Profile
Labcorp
Disseminated Intravascular Coagulation (DIC) Profile
Labcorp
COVID-19 Poor Outcomes Risk Profile
Labcorp
Prolonged Protime Profile
Labcorp
Prolonged Clot Time Reflexive Profile
ARUP Laboratories
Long COVID Profile
Labcorp
ThrombAssure Enhanced™
Labcorp
Lupus Anticoagulant Profile (Esoterix)
Labcorp